Impact of Impending Election and Medicare Legislation on Prescription Drug Pricing and Marketing Practices to be Addressed at IIR's Pharmaceutical Marketing Congress.

NEW YORK -- The potential impact of the impending U.S. Presidential election on prescription drug pricing and marketing practices has become a source for heated debate among many key legislators and pharmaceutical executives. On September 27-29 in Philadelphia, The Pharmaceutical Marketing Congress (PMC), will convene some of the industry's most influential decision-makers in an expert panel that will debate and provide insight on issues including the recent rise in drug importation, parallel importation, pricing and the passage of Medicare Prescription Drug legislation.

PMC, which has earned its rank as the leading industry event for pharmaceutical business executives and marketing professionals, will this year convene keynote presenters including Rep. Henry Waxman (D-Calif.); Kenneth Bowler, Vice President of Government Relations, Pfizer; Lynda Fishman, a former CME employee and Senior Health Policy Advisor for Hogan and Hartson; Glenn Mattes, President, ORTHO BIOTECH; Mike Pucci, Vice President, External Advocacy, GlaxoSmithKline and more.

PMC will address all of the key issues and trends impacting pharmaceutical marketing professionals while providing a unique, bipartisan forum for both regulators and marketers to share the floor and voice their opinions. Additional topics to be covered at PMC include the impact of political and regulatory restrictions on drug promotion, achieving brand success under new FDA guidance of direct-to-consumer (DTC) marketing, drug counterfeiting and re-importation's impact on your marketing returns.

"More than any other sector in the economy, the pharmaceutical industry is in a time of transition due to government legislation of drug pricing and re-importation and changing regulatory guidelines impacting marketing practices," said Bryon Main, program director, PMC. "No one can predict with certainty what impact this legislation and the upcoming election will have on the pharmaceutical industry, but none are better qualified to offer perspective and insight than those who will be speaking at PMC in September."

Representative examples of the more than 70 presentations at PMC include:

From Pharmaceutical "Mega-Marketing" of Blockbusters to "Multi-Marketing": New Directions in Overcoming Multiple Challenges in the New Landscape

Pharmaceutical Industry's Public Standing: Issues and Challenges to Face as We Approach Medicare Coverage

Transforming the Medicare Prescription Drug Legislation into an Opportunity: Creating a Roadmap for Re-Evaluating your Product and Brand Management Strategies, Sales Approaches and Processes

Grassroots Campaign Model for "The Value of Medicine": Positively Influencing Public Opinion towards Prescription Medicine

Update from DDMAC -- Structure and Mission, DTC Initiatives and Recent Enforcement Actions

About the Pharmaceutical Marketing Congress

The Pharmaceutical Marketing Congress is the world's largest pharmaceutical marketing conference bringing together the marketing community to maximize brand innovation, effectiveness, compliance and profitability leading to innovations in healthcare improving public health. For registration and further details, please visit us online at http://www.pharmaevent.com or call [phone].